NLRP3 and cardiovascular disorder: Overall, the ability of members of the NLRP3 inflammasome protein complex to target molecular and cellular pathways involved in both metabolic and cardiovascular diseases suggest that selective pharmacological modulation of NLRP3 inflammasome has the potential to exert synergistic effects in the control of metabolic disorders and its cardiovascular complications.